Tatsuya Konishi

Ehime University Graduate School of Medicine

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (18)

Collaborators (5)

Noritaka Sekiya

Associate Professor

Institute of Science Tokyo

Shinsuke Kusakabe

Osaka University

TAKASHI IKEDA

Junya Kanda

講師 / Senior Lecturer/ Junior Associate Professor

Kyoto University

RYUTA WATANABE

Fred Hutchinson Cancer Research Center

UNITED STATES

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tatsuya Konishi

Research Interests

Explore related searches

Contact this professor

Articles (18)

Collaborators (5)

Noritaka Sekiya

Shinsuke Kusakabe

TAKASHI IKEDA

Junya Kanda

RYUTA WATANABE

Make your next move.

Tatsuya Konishi

Research Interests

Explore related searches

Contact this professor

Articles (18)

Impact of Early Cytomegalovirus Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation on Relapse in Patients With Myelodysplastic Syndrome: A Nationwide Retrospective Study From Adult Myelodysplastic Syndrome Working Group of the JSTCT

Lower-dose post-transplant cyclophosphamide in haploidentical hematopoietic cell transplantation

Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignancies

Phase I trial of myeloablative conditioning with 3‐day total marrow and lymphoid irradiation for leukemia

Reinforced antimyeloma therapy via dual-lymphoid activation mediated by a panel of antibodies armed with bridging-BiTE

Impact of gene alterations on clinical outcome in young adults with myelodysplastic syndromes

Low- versus standard-dose post-transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation

Central nervous system mucormycosis in a patient with hematological malignancy: A case report and review of the literature

CD21<sup>lo</sup> B Cells Could Be a Potential Predictor of Immune-Related Adverse Events in Renal Cell Carcinoma

Cyclophosphamide-induced cardiotoxicity at conditioning for allogeneic hematopoietic stem cell transplantation would occur among the patients treated with 120 mg/kg or less.

Letter to the Editor: Very low-dose antithymocyte globulin (thymoglobulin) is effective for steroid-refractory acute graft-versus-host disease involving the skin or gut after allogeneic hematopoietic stem cell transplantation.

[A favorable clinical course of acute myeloid leukemia with t (6;21;8)(p23;q22;q22)].

Phase I trial of myeloablative conditioning with 3-day total marrow and lymphoid irradiation for leukemia

Central nervous system mucormycosis in a patient with hematological malignancy: A case report and review of the literature

Retrospective comparison of hematopoietic stem cell transplantation following reduced-intensity conditioning with fludarabine/low-dose melphalan plus 4 Gy TBI versus fludarabine/ busulfan plus 4 Gy TBI.

Outcome of allogeneic hematopoietic stem cell transplantation for T-cell lymphoblastic leukemia/lymphoma: A single-center study.

Changes in vaccination strategies contribute to the development of invasive pneumococcal disease in allogeneic hematopoietic stem cell transplantation recipients: a retrospective study for promoting vaccination.

Low diversity of gut microbiota in the early phase of post-bone marrow transplantation increases the risk of chronic graft-versus-host disease.

Collaborators (5)

Noritaka Sekiya

Shinsuke Kusakabe

TAKASHI IKEDA

Junya Kanda

RYUTA WATANABE

Make your next move.